Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Sasol Ltd. American Depositary Shares (SSL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Sasol Ltd. American Depositary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.44 (market cap $6.04B), while Sasol Ltd. American Depositary Shares trades at $14.46 (market cap $9.69B). The key difference: Sasol Ltd. American Depositary Shares is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 2,297,057). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Sasol Ltd. American Depositary Shares for 0 Days on average.
| IOVA | SSL | |
|---|---|---|
Market Cap | $6.04B | $9.69B |
Volume | 14,805,993 | 2,297,057 |
Sector | Health | Basic Materials |
52-Week High | $14.82 | $15.14 |
52-Week Low | $1.81 | $5.33 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $13.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Sasol Ltd. American Depositary Shares
Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →
